• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of Inhibition of Inflammatory Cell Migration into Lung Tissue by Ammeriolation of Cell Adhesion on Vascular Endothelial Cell

Research Project

Project/Area Number 12670581
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionNippon Medical School

Principal Investigator

AZUMA Arata  Nippon Medical School, Fourth Dept. Int. Med., Assistant Professor, 医学部, 講師 (10184194)

Co-Investigator(Kenkyū-buntansha) KUDOH Shoji  Nippon Medical School, Fourth Dept. Int. Med., Professor, 医学部, 教授 (40256912)
Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 2001: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2000: ¥1,200,000 (Direct Cost: ¥1,200,000)
Keywordserythromycin / macrolide / lung fibrosis / interstitial pneumonia / neutrophil / adhesion molecule / vascular endothelium / VCAM-1 / 血管内皮
Research Abstract

Background and objective : Although the pathogeneses of interstitial pneumonia and pulmonary fibrosis are not well understood, it has been reported that inflammatory cells, especially neutrophils, and injurious substances produced by them play important roles in the progression of interstitial pneumonia and subsequent fibrosis. Erythromycin and other 14-membered ring macrolides (14-MRMLs) have been reported to improve the survival of patients with diffuse panbronchiolitis (DPB) by anti-neutrophil and several other anti-inflammatory mechanisms. The present study was undertaken to investigate the effete of 14-MRMLs on an experimental model of bleomycin (BLM)-induced acute lung injury and subsequent fibrosis in mice.
Methods : BLM was administered intravenously to ICR mice. At 28 days after BLM injection, fibrotic foci were histologically observed in left lung tissues, and hydroxyproline (HOP) content in right lung tissues was chemically analyzed. The inhibitory effects of 14-MRMLs were as … More sessed by overall comparison between control (NS alone), untreated (BLM alone), and treated (BLM + 14-MRMLs) groups. For evaluation of early-phase inflammation, cell populations in bronchoalveolar lavage fluid (BALF) and induction of mRNA of adhesion molecules (E-selectin, P-selectin, ICAM-1, VCAM-1) in lung tissues were examined at 0 to 13 days after BLM. These parameters were also compared wife those for the control (NS alone), 14-MRML-unteated (BLM alone) and -pre-treated (BLM + pre14-MRMLs) groups.
Results : BLM-induced pulmonary fibrosis was inhibited by erythromycin and other 14-MRMLs on day 28 after BLM injection in ICR mice, especially those pre-treated with 14-MRMLs, HOP content in lung tissues was also decreased in the l4-MRML-pre-1reated groups. The number of neutrophils in BALF significantly increased, with two peaks at 1 and 9 (from 6 to 11) days after BLM administration. 14-MRMLs significantly inhibited both peaks of neutrophil infiltration into the airspace. Changes in mRNA expression of adhesion molecules (E-selectin, P-selectin, ICAM-1, VCAM-1) were associated with leucocyte migration into the airspace. 14-MRMLs clearly inhibited the induction of VCAM-1 mRNA and tended to attenuate that of ICAM-1 mRNA, but inhibited the induction of neither E-selectin mRNA nor P-selectin mRNA.
Conclusion : These findings indicate that attenuation of inflammatory cell migration into the airspace by 14-MRMLs, especially of neutrophils and macrophages, resulted in inhibition of lung injury and subsequent fibrosis. 14-MRMLs clearly attenuated the expression of VCAM- 1 mRNA during the early phase of BLM-induced lung injury, and this might be one mechanism of inhibition of neutrophil and macrophage migration into the airspace by 14-MRMLs. This might be one potent mechanism of the anti-inflammatory and subsequent fibrotic effects of 14-MRMLs. These findings suggest that prophylactic administration of 14-MRMLs may be clinically efficacious in preventing acute exacerbation of interstitial pneumonia and acute lung injury. Less

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (11 results)

All Other

All Publications (11 results)

  • [Publications] A.Azuma, Y.J.Li, J.Usuki, A.Aoyama, T.Enomoto, S.Kudoh: "Fourteen Membered-Ring Macrolides Inhibit The VCAM-1 mRNA Induction Preventing Neutrophil Induced Lung Injuey and Fibrosis in Bleomycin Callemged Mice"Chest. 120S. 20-22 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Arata, Azuma: "Novel Activity of Erythromycin Derivatives on Inflammatory Lung Diseases"Recent Res.Developments In Respir.& Crit.Care Medicine. 1. 191-207 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 李 英姫, 吾妻安良太, 工藤翔二ほか: "ブレオマイシン肺線維症に対する14員環マクロライドの抑制作用の検討"Jpn.J.Antibiotics. 54 Suppl.A. 87-91 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] 李 英姫, 吾妻安良太, 工藤翔二ほか: "ブレオマイシン急性肺傷害に対する14員環マクロライドの抑制作用"J.Nippon Medical School. 69(3)(in press). (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] S Kudoh, A Azuma, J Tamaoki, H Takizawa, H Goto, K Nakata: "Macrolide Antibiotics, ed.by S Omura"Novel Activity of Erythromycin and Its Derivatives(in press). 533-569 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] A. Azuma, Y.J. Li, J. Usuki, A. Aoyama, T. Enomoto, S. Kudoh: "Fourteen Membered-Ring Macrolides Inhibit The VCAM-1 mRNA Induction Preventing Neutrophil Induced Lung Injuey and Fibrosis in Bleomycin Callemged Mice"Chest. 120S. 20-22 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Arata Azuma: "Novel Activity of Erythromycin Derivatives on Inflammatory Lung Diseases"Recent Res. Developments In Respir. & Crit. Care Medicine. 1. 191-207 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 李 英姫, 吾妻安良太, 工藤翔二ほか: "プレオマイシン肺線維症に対する14員環マクロライドの抑制作用の検討"Jpn. J. Antibiotics. 54 Suppl.A. 87-91 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] 李 英姫, 吾妻安良太, 工藤翔二ほか: "プレオマイシン急性肺傷害に対する14員環マクロライドの抑制作用"J. Nippon Medical School. 69(3)(in press). (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] S. Kudoh, A. Azuma, J. Tamaoki, H. Takizawa, H. Goto, K. Nakata: "Macrolide Antibiotics, ed. by S Omura(in press)"Novel Activity of Erythromycin and Its Derivatives. 533-569 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] 李英姫,吾妻安良太,工藤翔二 ほか: "ブレオマイシン肺線維症に対する14員環マクロライドの抑制作用の検討"Jpn.J.Antibiotics. 54 Suppl.A. 87-91 (2001)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2000-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi